Skip to main content
. 2010 Mar 30;25(6):489–494. doi: 10.1007/s11606-010-1296-y

Table 1.

Patient and Hospital Characteristics Associated with Early VTE Prophylaxis

Total Early prophylaxis (by Day 2)
Predictors N Column % N Row % p-value
351,535 100.0 125,433 35.7
Demographics
Age <0.001
18–49 38,773 (11.0) 12,457 (32.1)
50–64 69,311 (19.7) 26,582 (38.4)
65–79 123,387 (35.1) 46,069 (37.3)
80+ 120,064 (34.2) 40,325 (33.6)
Gender <0.001
Male 147,910 (42.1) 54,211 (36.7)
Female 203,616 (57.9) 71,218 (35.0)
Race <0.001
White 231,184 (65.8) 81,739 (35.4)
Black 55,712 (15.8) 22,517 (40.4)
Hispanic 13,745 (3.9) 4,742 (34.5)
Other 50,894 (14.5) 16,435 (32.3)
Primary diagnosis <0.001
Community-acquired pneumonia 108,639 (30.9) 33,098 (30.5)
Septicemia 11,576 (3.3) 4,494 (38.8)
Chronic obstructive pulmonary disease 45,888 (13.1) 15,152 (33.0)
Respiratory failure 13,015 (3.7) 8,007 (61.5)
Congestive heart failure 85,222 (24.2) 36,359 (42.7)
Stroke 49,557 (14.1) 20,656 (41.7)
Urinary tract infection 37,638 (10.7) 7,667 (20.4)
Attending specialty <0.001
Internist 190,284 (54.1) 70,459 (37.0)
GP/family medicine 71,765 (20.4) 19,118 (26.6)
Cardiologist 25,508 (7.3) 10,467 (41.0)
Pulmonologist 21,009 (6.0) 8,955 (42.6)
Nephrology 8,522 (2.4) 2,521 (29.6)
Other 34,447 (9.8) 13,913 (40.4)
Insurance payor <0.001
Medicare traditional 235,033 (66.9) 82,534 (35.1)
Medicare-managed care 16,347 (4.7) 6,477 (39.6)
Medicaid 23,120 (6.6) 8,511 (36.8)
Private 61,505 (17.5) 22,388 (36.4)
Self-pay/uninsured/other 15,530 (4.4) 5,523 (35.6)
Risk factors for VTE
Admitted from skilled nursing facility 4,460 (1.3) 1,523 (34.1) 0.03
Paralysis 25,311 (7.2) 10,770 (42.6) <0.001
Restraints 4,759 (1.4) 2,690 (56.5) <0.001
Decubitus ulcer 10,591 (3.0) 4,143 (39.1) <0.001
Cancer 48,180 (13.7) 16,527 (34.3) <0.001
Chemotherapy 1,033 (0.3) 358 (34.7) 0.49
Prior venous thromboembolism 5,553 (1.6) 2,445 (44.0) <0.001
Pregnancy 27 (0.0) 7 (25.9) 0.29
Estrogens 5,368 (1.5) 1,594 (29.7) <0.001
Estrogen modulators 2,648 (0.8) 818 (30.9) <0.001
Secondary diagnosis of atrial fibrillation 57,192 (16.3) 25,134 (43.9) <0.001
Prosthetic heart valve 3,250 (0.9) 1,145 (35.2) 0.59
Congestive heart failure 35,116 (10.0) 15,673 (44.6) <0.001
Respiratory failure-secondary diagnosis 24,760 (7.0) 13,144 (53.1) <0.001
Inflammatory bowel disease 1,149 (0.3) 382 (33.2) 0.08
Nephrotic syndrome 794 (0.2) 319 (40.2) 0.008
Myeloproliferative disorder 3,118 (0.9) 1,063 (34.1) 0.06
Paroxysmal nocturnal hemoglobinuria 9 (0.0) 3 (33.3) 0.88
Obesity 26,705 (7.6) 12,169 (45.6) <0.001
Smoking 47,139 (13.4) 18,150 (38.5) <0.001
Varicose veins 309 (0.1) 98 (31.7) 0.15
Central line 10,662 (3.0) 5,872 (55.1) <0.001
Inherited or acquired thrombophilia 295 (0.1) 127 (43.1) 0.008
Diabetes mellitus 110,717 (31.5) 42,407 (38.3) <0.001
Mechanical ventilation 18,808 (5.4) 12,585 (66.9) <0.001
Computed risk of VTE <0.001
<0.5% 278,807 (79.3) 94,195 (33.8)
0.5% to 1.0% 49,587 (14.1) 19,221 (38.8)
>1.0% 23,132 (6.6) 12,013 (51.9)
Hospital characteristics
Region <0.001
South 193,848 (55.1) 68,258 (35.2)
Midwest 66,364 (18.9) 25,744 (38.8)
West 38,175 (10.9) 10,435 (27.3)
Northeast 53,148 (15.1) 20,996 (39.5)
Number of beds <0.001
0–200 61,287 (17.4) 15,931 (26.0)
201–300 57,205 (16.3) 17,491 (30.6)
301–500 126,695 (36.0) 46,454 (36.7)
>500 106,348 (30.3) 45,557 (42.8)
Teaching hospital 117,949 (33.6) 50,336 (42.7) <0.001
Rural hospital 75,058 (21.4) 21,174 (28.2) <0.001